Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Axogen Inc (AXGN)

Axogen Inc (AXGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 316,424
  • Shares Outstanding, K 43,705
  • Annual Sales, $ 159,010 K
  • Annual Income, $ -21,720 K
  • 60-Month Beta 1.06
  • Price/Sales 1.98
  • Price/Cash Flow N/A
  • Price/Book 3.39
Trade AXGN with:

Options Overview Details

View History
  • Implied Volatility 33.53% ( -36.19%)
  • Historical Volatility 48.63%
  • IV Percentile 6%
  • IV Rank 14.87%
  • IV High 215.06% on 05/02/24
  • IV Low 1.83% on 11/09/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 7
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 1,391
  • Open Int (30-Day) 1,376

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.13
  • Number of Estimates 2
  • High Estimate -0.12
  • Low Estimate -0.14
  • Prior Year -0.16
  • Growth Rate Est. (year over year) +18.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.39 +13.30%
on 05/29/24
8.22 -11.92%
on 06/12/24
+0.60 (+9.04%)
since 05/28/24
3-Month
5.55 +30.45%
on 05/06/24
8.25 -12.24%
on 04/04/24
-0.83 (-10.29%)
since 03/28/24
52-Week
3.45 +109.86%
on 11/01/23
10.83 -33.16%
on 02/27/24
-1.74 (-19.38%)
since 06/28/23

Most Recent Stories

More News
AxoGen: Q1 Earnings Snapshot

AxoGen: Q1 Earnings Snapshot

AXGN : 7.24 (+0.28%)
AxoGen: Q4 Earnings Snapshot

AxoGen: Q4 Earnings Snapshot

AXGN : 7.24 (+0.28%)
AxoGen: Q3 Earnings Snapshot

AxoGen: Q3 Earnings Snapshot

AXGN : 7.24 (+0.28%)
AxoGen: Q2 Earnings Snapshot

AxoGen: Q2 Earnings Snapshot

AXGN : 7.24 (+0.28%)
AxoGen: Q1 Earnings Snapshot

AxoGen: Q1 Earnings Snapshot

AXGN : 7.24 (+0.28%)
AxoGen: Q4 Earnings Snapshot

AxoGen: Q4 Earnings Snapshot

AXGN : 7.24 (+0.28%)
ViewRay Announces Preliminary Fourth Quarter and Full Year 2022 Results; appoints William P. "Bill" Burke as Chief Financial Officer

/PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced preliminary financial results for the fourth quarter and full fiscal year ended...

MIRO : 3.39 (+0.59%)
AXGN : 7.24 (+0.28%)
VRAY : 0.0250 (-39.90%)
Axogen, Inc Reports 2022 Second Quarter Financial Results

ALACHUA, Fla. and TAMPA, Fla., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...

AXGN : 7.24 (+0.28%)
Axogen, Inc. to present at Canaccord Genuity's 42nd Annual Growth Conference

ALACHUA. Fla. and TAMPA, Fla, July 29, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...

AXGN : 7.24 (+0.28%)
Axogen, Inc. Announces Organizational Updates, Preliminary Second Quarter Revenue and Reaffirms Full-Year 2022 Financial Guidance

Organizational updates are part of plan to bring additional focus on leveraging clinical data to accelerate market development and the pace of innovation ...

AXGN : 7.24 (+0.28%)

Business Summary

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch...

See More

Key Turning Points

3rd Resistance Point 7.61
2nd Resistance Point 7.48
1st Resistance Point 7.36
Last Price 7.24
1st Support Level 7.11
2nd Support Level 6.97
3rd Support Level 6.85

See More

52-Week High 10.83
Fibonacci 61.8% 8.01
Last Price 7.24
Fibonacci 50% 7.14
Fibonacci 38.2% 6.27
52-Week Low 3.45

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar